Currently, there is no standard treatment for these patients,” says Ian Krop, an oncologist at the Dana–Farber Cancer Institute in Boston, USA, and lead investigator of the TDM4374g trial.

Ian Randall is Newsweek's Deputy Science Editor, based in Royston, U.K. His focus is reporting on science and health. He has covered archeology, geology, and physics extensively. Ian joined ...

End the day in the company of the song writing masters of country, folk, blues, soul and rock'n'roll.